Gene rearrangement: a novel mechanism for MDR-1 gene activation. (original) (raw)

J Clin Invest. 1997 Apr 15; 99(8): 1947–1957.

Medicine Branch, DCS, NCI, Bethesda, Maryland 20892, USA.

Abstract

Drug resistance, a major obstacle to cancer chemotherapy, can be mediated by MDR-1/P-glycoprotein. Deletion of the first 68 residues of MDR-1 in an adriamycin-selected cell line after a 4;7 translocation, t(4q;7q), resulted in a hybrid mRNA containing sequences from both MDR-1 and a novel chromosome 4 gene. Further selection resulted in amplification of a hybrid gene. Expression of the hybrid mRNA was controlled by the chromosome 4 gene, providing a model for overexpression of MDR-1. Additional hybrid mRNAs in other drug-selected cell lines and in patients with refractory leukemia, with MDR-1 juxtaposed 3' to an active gene, establishes random chromosomal rearrangements with overexpression of hybrid MDR-1 mRNAs as a mechanism of acquired drug resistance.

Full Text

The Full Text of this article is available as a PDF (670K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation